Stock AGN AEGON N.V.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Aegon N.V. Euronext Amsterdam

Equities

AGN

NL0000303709

Life & Health Insurance

Market Closed - Euronext Amsterdam
Other stock markets
 11:35:28 2024-04-26 am EDT 		5-day change 1st Jan Change
5.82 EUR +1.61% Intraday chart for Aegon N.V. +4.19% +10.90%
Apr. 10 Aegon: successful placement of bond issue CF
Apr. 10 Aegon Prices $760 Million Note for General Corporate Purposes MT

Valuation

Fiscal Period: Dezember 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 8,056 6,538 8,826 9,141 8,212 10,196 - -
Enterprise Value (EV) 1 7,443 -1,834 13,792 12,080 8,212 10,196 10,196 10,196
P/E ratio 5.28 x 162 x 5.49 x -3.79 x -43.7 x 8.94 x 6.88 x 7.13 x
Yield 7.62% 3.71% 3.87% 4.85% - 6.05% 6.93% 7.41%
Capitalization / Revenue 0.44 x 0.41 x 0.57 x 0.62 x - 0.79 x 0.72 x 0.66 x
EV / Revenue 0.44 x 0.41 x 0.57 x 0.62 x - 0.79 x 0.72 x 0.66 x
EV / EBITDA - - - - - - - -
EV / FCF 1.12 x 13.6 x 12.1 x 11.7 x - 12.2 x 11 x 8.07 x
FCF Yield 89.4% 7.37% 8.26% 8.53% - 8.17% 9.08% 12.4%
Price to Book 0.36 x 0.29 x 0.37 x 0.83 x - 1.01 x 0.97 x 0.88 x
Nbr of stocks (in thousands) 1,980,832 2,021,164 2,009,073 1,929,320 1,564,872 1,751,952 - -
Reference price 2 4.067 3.235 4.393 4.738 5.248 5.820 5.820 5.820
Announcement Date 2/13/20 2/11/21 2/9/22 2/9/23 3/1/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 18,138 16,099 15,444 14,761 - 12,937 14,148 15,415
EBITDA - - - - - - - -
EBIT 1 1,973 1,729 1,906 1,918 1,498 1,637 1,673 1,727
Operating Margin 10.88% 10.74% 12.34% 12.99% - 12.65% 11.83% 11.2%
Earnings before Tax (EBT) 1 1,872 -84 2,056 -2,319 -317 1,589 1,777 1,977
Net income 1 1,528 55 1,651 -2,533 -247 1,217 1,381 1,360
Net margin 8.42% 0.34% 10.69% -17.16% - 9.41% 9.76% 8.82%
EPS 2 0.7700 0.0200 0.8000 -1.250 -0.1200 0.6508 0.8460 0.8165
Free Cash Flow 1 7,200 482 729 780 - 833.2 925.3 1,263
FCF margin 39.7% 2.99% 4.72% 5.28% - 6.44% 6.54% 8.19%
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) 471.2% 876.36% 44.16% - - 68.48% 66.98% 92.88%
Dividend per Share 2 0.3100 0.1200 0.1700 0.2300 - 0.3520 0.4033 0.4312
Announcement Date 2/13/20 2/11/21 2/9/22 2/9/23 3/1/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S2 2020 S1 2020 S2 2021 S1 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q2 2023 S1 2024 S1 2024 S2
Net sales - - - - 3,662 3,915 - 6,188 3,651 3,577 - - - -
EBITDA - - - - - - - - - - - - - -
EBIT - 710 - - 443 470 463 538 429 488 - - - -
Operating Margin - - - - 12.1% 12.01% - 8.69% 11.75% 13.64% - - - -
Earnings before Tax (EBT) 1,105 111 -195 - -107 627 394 -454 -300 -1,978 - - - -
Net income 910 202 - - -60 504 385 -365 -200 -2,352 - - - -
Net margin - - - - -1.64% 12.87% - -5.9% -5.48% -65.75% - - - -
EPS 0.4500 0.0800 - - -0.0400 0.2500 0.1900 -0.1900 -0.1000 -1.180 - - 0.2500 0.2600
Dividend per Share 1 0.1600 0.0600 0.0600 0.0800 - 0.0900 - 0.1100 - 0.1200 0.1400 0.1400 0.1600 0.2100
Announcement Date 2/13/20 8/13/20 2/11/21 8/12/21 11/11/21 2/9/22 5/12/22 8/11/22 11/10/22 2/9/23 9/1/23 - - -
1EUR
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - 4,966 2,939 - - - -
Net Cash position 613 8,372 - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 7,200 482 729 780 - 833 925 1,263
ROE (net income / shareholders' equity) 9.6% 8.5% 6.35% -14.2% - 11.8% 12.5% 13%
ROA (Net income/ Total Assets) 0.37% 0.32% 0.34% 0.34% - 0.1% 0.1% 0.2%
Assets 1 417,065 17,405 492,395 -736,337 - 1,216,771 1,381,447 679,903
Book Value Per Share 2 11.20 11.10 11.90 5.740 - 5.790 6.020 6.590
Cash Flow per Share 3.580 -1.390 -0.8700 - - - - -
Capex 1 - 80 - - - 180 177 175
Capex / Sales - 0.5% - - - 1.39% 1.25% 1.14%
Announcement Date 2/13/20 2/11/21 2/9/22 2/9/23 3/1/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Aegon N.V.

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
5.82 EUR
Average target price
5.897 EUR
Spread / Average Target
+1.33%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Life & Health Insurance

1st Jan change Capi.
METLIFE, INC. Stock MetLife, Inc.
+6.49% 50.92B
AFLAC INCORPORATED Stock Aflac Incorporated
+1.35% 48.11B
MANULIFE FINANCIAL CORPORATION Stock Manulife Financial Corporation
+9.53% 42.2B
PRUDENTIAL FINANCIAL, INC. Stock Prudential Financial, Inc.
+6.55% 39.71B
GENERALI Stock Generali
+19.34% 37.78B
SUN LIFE FINANCIAL INC. Stock Sun Life Financial Inc.
+2.84% 30.07B
GREAT-WEST LIFECO INC. Stock Great-West Lifeco Inc.
-7.77% 27.56B
PRUDENTIAL PLC Stock Prudential plc
-18.42% 24.71B
CATHAY FINANCIAL HOLDING CO., LTD. Stock Cathay Financial Holding Co., Ltd.
+6.89% 21.99B
Other Life & Health Insurance
  1. Stock Market
  2. Equities
  3. AGN Stock
  4. AGN Stock
  5. Financials Aegon N.V.